Discover November 2024's Top Penny Stocks

In This Article:

As global markets react to recent political shifts and economic policies, major indices have reached new heights, with U.S. stocks rallying on expectations of growth and tax reforms. In this context, the often-overlooked realm of penny stocks presents intriguing opportunities for investors seeking potential value in smaller or newer companies. Despite their name suggesting a bygone era, penny stocks can offer significant returns when backed by strong financials and growth prospects.

Top 10 Penny Stocks

Name

Share Price

Market Cap

Financial Health Rating

BP Plastics Holding Bhd (KLSE:BPPLAS)

MYR1.22

MYR343.4M

★★★★★★

DXN Holdings Bhd (KLSE:DXN)

MYR0.475

MYR2.36B

★★★★★★

Rexit Berhad (KLSE:REXIT)

MYR0.78

MYR135.97M

★★★★★★

Seafco (SET:SEAFCO)

THB1.92

THB1.67B

★★★★★★

LaserBond (ASX:LBL)

A$0.615

A$71.21M

★★★★★★

Hil Industries Berhad (KLSE:HIL)

MYR0.87

MYR287.13M

★★★★★★

Wellcall Holdings Berhad (KLSE:WELLCAL)

MYR1.55

MYR761.86M

★★★★★★

Lever Style (SEHK:1346)

HK$0.87

HK$545.92M

★★★★★★

Embark Early Education (ASX:EVO)

A$0.80

A$140.36M

★★★★☆☆

Next 15 Group (AIM:NFG)

£3.8789

£385.78M

★★★★☆☆

Click here to see the full list of 5,781 stocks from our Penny Stocks screener.

Let's uncover some gems from our specialized screener.

Impact Coatings

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Impact Coatings AB (publ) offers physical vapor deposition (PVD) surface treatment solutions for hydrogen and metallization applications globally, with a market cap of SEK418.19 million.

Operations: The company generates revenue from its Specialty Chemicals segment, totaling SEK128.7 million.

Market Cap: SEK418.19M

Impact Coatings AB, with a market cap of SEK418.19 million, has shown recent improvements in its financial performance despite being unprofitable. The company reported increased sales and reduced net losses for the third quarter of 2024 compared to the previous year. Its short-term assets exceed liabilities, providing some financial stability, although it faces challenges with long-term liabilities coverage and a limited cash runway under current free cash flow conditions. The management team's relative inexperience could impact strategic execution; however, no significant shareholder dilution occurred recently. Earnings are forecasted to grow significantly, offering potential upside for investors interested in speculative opportunities within the specialty chemicals sector.

OM:IMPC Debt to Equity History and Analysis as at Nov 2024
OM:IMPC Debt to Equity History and Analysis as at Nov 2024

SpectraCure

Simply Wall St Financial Health Rating: ★★★★★☆